179 related articles for article (PubMed ID: 27771376)
1. Clinicopathological characteristics of invasive gastric Helicobacter pylori.
Dudley J; Wieczorek T; Selig M; Cheung H; Shen J; Odze R; Deshpande V; Zukerberg L
Hum Pathol; 2017 Mar; 61():19-25. PubMed ID: 27771376
[TBL] [Abstract][Full Text] [Related]
2. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
Nasser SC; Slim M; Nassif JG; Nasser SM
World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
[TBL] [Abstract][Full Text] [Related]
3. Nodular gastritis in adults: clinical features, endoscopic appearance, histopathological features, and response to therapy.
Dwivedi M; Misra SP; Misra V
J Gastroenterol Hepatol; 2008 Jun; 23(6):943-7. PubMed ID: 17614956
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori-negative gastritis: seek, yet ye shall not always find.
Genta RM; Lash RH
Am J Surg Pathol; 2010 Aug; 34(8):e25-34. PubMed ID: 20631607
[TBL] [Abstract][Full Text] [Related]
5. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
Kyzekova J; Mour J
Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
[TBL] [Abstract][Full Text] [Related]
6. Effects of Proton Pump Inhibitor on the Distribution of Helicobacter pylori and Associated Gastritis in Patients with Gastric Atrophy.
Gong EJ; Kim DH; Ahn JY; Na HK; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Park Y; Kim MJ
Digestion; 2020; 101(3):279-286. PubMed ID: 31067538
[TBL] [Abstract][Full Text] [Related]
7. Infiltration of Helicobacter pylori in the gastric mucosa.
Jhala NC; Siegal GP; Klemm K; Atkinson BF; Jhala DN
Am J Clin Pathol; 2003 Jan; 119(1):101-7. PubMed ID: 12520704
[TBL] [Abstract][Full Text] [Related]
8. The Reduction in Gastric Atrophy after
Niikura R; Hayakawa Y; Hirata Y; Ogura K; Fujishiro M; Yamada A; Ushiku T; Konishi M; Fukayama M; Koike K
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003453
[TBL] [Abstract][Full Text] [Related]
9. Gastrospirillum hominis and Helicobacter pylori infection in Thai individuals: comparison of histopathological changes of gastric mucosa.
Yali Z; Yamada N; Wen M; Matsuhisa T; Miki M
Pathol Int; 1998 Jul; 48(7):507-11. PubMed ID: 9701012
[TBL] [Abstract][Full Text] [Related]
10. The association between Helicobacter pylori gastritis and lymphoid aggregates, lymphoid follicles and intestinal metaplasia in gastric mucosa of children.
Kara N; Urganci N; Kalyoncu D; Yilmaz B
J Paediatr Child Health; 2014 Aug; 50(8):605-9. PubMed ID: 24925694
[TBL] [Abstract][Full Text] [Related]
11. Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study.
Abut E; Yaşar B; Güveli H; Bölükbaş C; Bölükbaş FF; Dalay AR; Kurdaş OO
Scand J Gastroenterol; 2010 Jun; 45(6):677-83. PubMed ID: 20334478
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa].
Unger Z; Prónai L; Szaleczky E; Zágoni T; Molnár B; Tulassay Z
Orv Hetil; 2000 Dec; 141(50):2695-700. PubMed ID: 11189675
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors.
Kumar KR; Iqbal R; Coss E; Park C; Cryer B; Genta RM
Hum Pathol; 2013 Dec; 44(12):2706-10. PubMed ID: 24071014
[TBL] [Abstract][Full Text] [Related]
14. Anti-Helicobacter pylori activities of Chenopodium ambrosioides L. in vitro and in vivo.
Ye H; Liu Y; Li N; Yu J; Cheng H; Li J; Zhang XZ
World J Gastroenterol; 2015 Apr; 21(14):4178-83. PubMed ID: 25892867
[TBL] [Abstract][Full Text] [Related]
15. Increased plasmacytic differentiation in gastric mucosa-associated lymphoid tissue lymphomas: Helicobacter pylori eradication response and IgG4+ plasma cell association.
Park S; Ahn S; Hong M; Ko YH
Hum Pathol; 2017 Jan; 59():113-119. PubMed ID: 27697589
[TBL] [Abstract][Full Text] [Related]
16. Culture and successful eradication of Helicobacter pylori from heterotopic gastric mucosa.
Wüppenhorst N; Viebahn B; Theile A; Radü HJ; Kist M
Z Gastroenterol; 2012 Jul; 50(7):677-9. PubMed ID: 22760679
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
Koskenpato J; Färkkilä M; Sipponen P
Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
[TBL] [Abstract][Full Text] [Related]
18. Some ultrastructural aspects of Helicobacter pylori gastritis.
Bartel H; Orkisz S; Chojnacki J; Kulig A
Patol Pol; 1992; 43(1):16-8. PubMed ID: 1296168
[TBL] [Abstract][Full Text] [Related]
19. The value of different detection methods of Helicobacter pylori during treatment.
Adamsson I; Nord CE; Sjöstedt S; Wikström B; Seensalu R
J Clin Gastroenterol; 1998 Sep; 27(2):138-42. PubMed ID: 9754775
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter heilmannii gastritis: association with acid peptic diseases and comparison with Helicobacter pylori gastritis.
Jhala D; Jhala N; Lechago J; Haber M
Mod Pathol; 1999 May; 12(5):534-8. PubMed ID: 10349993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]